Nov 14 (Reuters) – Eli Lilly and Company: * ELI LILLY: PHASE 2 DATA SHOWED ELORATZP DELIVERED WEIGHT LOSS OF UP TO AVERAGE OF 54.1 LBS (23.3%) AT 48 WEEKS IN ADULTS WITH OBESITY, TYPE 2 DIABETES * ELI
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: ATP 250 STOCKHOLM OPEN FINAL HIGHLIGHTS WITH TAYLOR FRITZ BEATING THIAGO AGUSTIN TIRANTE…
By Patrick Wingrove LONDON Nov 14 - Patients who stayed on Novo Nordisk's daily Wegovy…
By David Shepardson and Doyinsola Oladipo WASHINGTON/NEWARK, New Jersey, Nov 14 (Reuters) - Major airlines…
* Wales outscore New Zealand five tries to four in huge upset * Costelow flawless…
VIDEO SHOWS: BELGIUM SOCCER SQUAD TRAINING FOR THE UEFA NATIONS LEAGUE MATCH AGAINST ITALY /…
Nov 14 (Reuters) - Novo Nordisk A/S: * NOVO NORDISK: CAGRISEMA 1.7 MG/1.7 MG ACHIEVED…